• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.解析组蛋白甲基化与非酒精性脂肪性肝病之间的关系。
World J Hepatol. 2024 May 27;16(5):703-715. doi: 10.4254/wjh.v16.i5.703.
2
Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease.组蛋白甲基化调控作为非酒精性脂肪性肝病的潜在靶点。
Curr Protein Pept Sci. 2023;24(6):465-476. doi: 10.2174/1389203724666230526155643.
3
Targeting histone methylation and demethylation for non-alcoholic fatty liver disease.针对非酒精性脂肪性肝病的组蛋白甲基化和去甲基化治疗。
Bioorg Chem. 2024 Oct;151:107698. doi: 10.1016/j.bioorg.2024.107698. Epub 2024 Aug 6.
4
Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.表观遗传学关联研究揭示了大鼠高脂饮食诱导的非酒精性脂肪性肝病中的H3K27乙酰化增强子和失调基因。
Epigenomics. 2022 Dec;14(23):1523-1540. doi: 10.2217/epi-2022-0362. Epub 2023 Feb 22.
5
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.遗传和表观遗传变异影响非酒精性脂肪性肝病的发生。
World J Gastroenterol. 2012 Dec 7;18(45):6546-51. doi: 10.3748/wjg.v18.i45.6546.
6
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.瘦型非酒精性脂肪性肝病中的表观遗传调控。
Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864.
7
Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.饮食模式通过非酒精性脂肪性肝病中新兴的表观遗传机制影响靶基因表达。
Biomedicines. 2021 Sep 18;9(9):1256. doi: 10.3390/biomedicines9091256.
8
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression.表观遗传修饰与非酒精性脂肪性肝病进展的串扰。
Pathol Res Pract. 2023 Nov;251:154809. doi: 10.1016/j.prp.2023.154809. Epub 2023 Sep 16.
9
Histone Modifications in NAFLD: Mechanisms and Potential Therapy.非酒精性脂肪性肝病中组蛋白修饰:机制与潜在治疗策略。
Int J Mol Sci. 2023 Sep 27;24(19):14653. doi: 10.3390/ijms241914653.
10
Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体-γ 作为非酒精性脂肪性肝病中表观遗传机制的靶点和调节剂。
Cells. 2023 Apr 21;12(8):1205. doi: 10.3390/cells12081205.

引用本文的文献

1
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.从毒素到治疗:环境污染物、肠道微生物群和天然化合物对非酒精性脂肪性肝病进展的影响
World J Hepatol. 2025 Aug 27;17(8):108772. doi: 10.4254/wjh.v17.i8.108772.

本文引用的文献

1
H4K20me3 upregulated by reactive oxygen species is associated with tumor progression and poor prognosis in patients with hepatocellular carcinoma.由活性氧上调的H4K20me3与肝细胞癌患者的肿瘤进展及不良预后相关。
Heliyon. 2023 Nov 20;9(12):e22589. doi: 10.1016/j.heliyon.2023.e22589. eCollection 2023 Dec.
2
Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants.慢性肝病中活性氧(ROS)介导的氧化应激及其药用植物缓解作用
Am J Transl Res. 2023 Nov 15;15(11):6321-6341. eCollection 2023.
3
Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment.探讨组蛋白去甲基化酶抑制在癌症多疗法中的治疗潜力。
Eur J Med Chem. 2024 Jan 15;264:115999. doi: 10.1016/j.ejmech.2023.115999. Epub 2023 Nov 29.
4
Recent developments in catalysis and inhibition of the Jumonji histone demethylases.组蛋白去甲基化酶 Jumonji 的催化和抑制的最新进展。
Curr Opin Struct Biol. 2023 Dec;83:102707. doi: 10.1016/j.sbi.2023.102707. Epub 2023 Oct 11.
5
LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.长链非编码 RNA H19 通过重编程 H3K27me3 谱促进肝纤维化。
Acta Pharmacol Sin. 2023 Dec;44(12):2479-2491. doi: 10.1038/s41401-023-01145-z. Epub 2023 Aug 14.
6
Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways.Ezh2 通过表观遗传调控 Wnt 和 mTORC1 信号通路促进乳腺肿瘤的起始。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2303010120. doi: 10.1073/pnas.2303010120. Epub 2023 Aug 7.
7
JARID2 and EZH2, the eminent epigenetic drivers in human cancer.JARID2 和 EZH2,人类癌症中重要的表观遗传学驱动因子。
Gene. 2023 Aug 30;879:147584. doi: 10.1016/j.gene.2023.147584. Epub 2023 Jun 21.
8
ROS inhibition increases KDM6A-mediated NOX2 transcription and promotes macrophages oxidative stress and M1 polarization.ROS 抑制增加了 KDM6A 介导的 NOX2 转录,促进了巨噬细胞的氧化应激和 M1 极化。
Cell Stress Chaperones. 2023 Jul;28(4):375-384. doi: 10.1007/s12192-023-01347-8. Epub 2023 May 4.
9
STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome.STING 通过表观遗传激活 NLRP3 炎性小体介导肝纤维化中的肝细胞细胞焦亡。
Redox Biol. 2023 Jun;62:102691. doi: 10.1016/j.redox.2023.102691. Epub 2023 Mar 29.
10
Epigenetics of methylation modifications in diabetic cardiomyopathy.糖尿病心肌病中甲基化修饰的表观遗传学
Front Endocrinol (Lausanne). 2023 Mar 15;14:1119765. doi: 10.3389/fendo.2023.1119765. eCollection 2023.

解析组蛋白甲基化与非酒精性脂肪性肝病之间的关系。

Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.

作者信息

Xu Li, Fan Yu-Hong, Zhang Xiao-Jing, Bai Lan

机构信息

State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases; Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou 341000, China.

School of Basic Medical Sciences, Wuhan University, Wuhan 430060, China; State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou 341000, China.

出版信息

World J Hepatol. 2024 May 27;16(5):703-715. doi: 10.4254/wjh.v16.i5.703.

DOI:10.4254/wjh.v16.i5.703
PMID:38818286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11135277/
Abstract

Non-alcoholic fatty liver disease (NAFLD) poses a significant health challenge in modern societies due to shifts in lifestyle and dietary habits. Its complexity stems from genetic predisposition, environmental influences, and metabolic factors. Epigenetic processes govern various cellular functions such as transcription, chromatin structure, and cell division. In NAFLD, these epigenetic tendencies, especially the process of histone methylation, are intricately intertwined with fat accumulation in the liver. Histone methylation is regulated by different enzymes like methyltransferases and demethylases and influences the expression of genes related to adipogenesis. While early-stage NAFLD is reversible, its progression to severe stages becomes almost irreversible. Therefore, early detection and intervention in NAFLD are crucial, and understanding the precise role of histone methylation in the early stages of NAFLD could be vital in halting or potentially reversing the progression of this disease.

摘要

由于生活方式和饮食习惯的改变,非酒精性脂肪性肝病(NAFLD)在现代社会中构成了重大的健康挑战。其复杂性源于遗传易感性、环境影响和代谢因素。表观遗传过程调控着各种细胞功能,如转录、染色质结构和细胞分裂。在NAFLD中,这些表观遗传倾向,尤其是组蛋白甲基化过程,与肝脏中的脂肪堆积错综复杂地交织在一起。组蛋白甲基化由甲基转移酶和去甲基酶等不同酶调控,并影响与脂肪生成相关基因的表达。虽然NAFLD早期阶段是可逆的,但其进展到严重阶段几乎不可逆转。因此,NAFLD的早期检测和干预至关重要,了解组蛋白甲基化在NAFLD早期的确切作用对于阻止或潜在逆转该疾病的进展可能至关重要。